chr21-42413418-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018961.4(UBASH3A):c.562G>A(p.Val188Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,246 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018961.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBASH3A | NM_018961.4 | c.562G>A | p.Val188Ile | missense_variant | 5/15 | ENST00000319294.11 | NP_061834.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBASH3A | ENST00000319294.11 | c.562G>A | p.Val188Ile | missense_variant | 5/15 | 1 | NM_018961.4 | ENSP00000317327 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250640Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135474
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1460994Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 726790
GnomAD4 genome AF: 0.000112 AC: 17AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.562G>A (p.V188I) alteration is located in exon 5 (coding exon 5) of the UBASH3A gene. This alteration results from a G to A substitution at nucleotide position 562, causing the valine (V) at amino acid position 188 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at